# A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors

> clinical trial · VERIFIED · 2026-07-24

Status: RECRUITING · Sponsor: Shanghai Henlius Biotech · Condition: Esophageal and/or Cardia Cancer

- Company: Shanghai Henlius Biotech
- Sector: Esophageal and/or Cardia Cancer
- Primary source: https://clinicaltrials.gov/study/NCT07518043

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.